Cargando…
Lymphocyte-depleted classic Hodgkin lymphoma with primary extranodal disease: Two cases that highlight the combination of immunodeficiency and immune escape in the pathogenesis
Neoplastic programmed cell death ligand 1 (PD-L1) expression, activated by PD-L1 gene alterations, is strongly associated with classic Hodgkin lymphoma (CHL). This association enabled a diagnostic consensus for lymphocyte-depleted CHL (LD-CHL), a previously enigmatic disease. We describe two patient...
Autores principales: | Tsuyuki, Yuta, Kohno, Kei, Inagaki, Yuichiro, Sakai, Yu, Kosugi, Hiroshi, Takahashi, Emiko, Suzuki, Yuka, Shimada, Satoko, Kato, Seiichi, Takahara, Taishi, Satou, Akira, Shimoyama, Yoshie, Nakamura, Shigeo, Asano, Naoko, Sakakibara, Ayako |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JSLRT
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519246/ https://www.ncbi.nlm.nih.gov/pubmed/34511545 http://dx.doi.org/10.3960/jslrt.21008 |
Ejemplares similares
-
Diagnostic utility of programmed cell death ligand 1 (clone SP142) immunohistochemistry for malignant lymphoma and lymphoproliferative disorders: A brief review
por: Sakakibara, Ayako, et al.
Publicado: (2021) -
Diagnostic approach for classic Hodgkin lymphoma in small samples with an emphasis on PD-L1 expression and EBV harboring in tumor cells: a brief review from morphology to biology
por: Takahara, Taishi, et al.
Publicado: (2023) -
PD‐L1 (SP142) expression in neoplastic cells predicts a poor prognosis for patients with intravascular large B‐cell lymphoma treated with rituximab‐based multi‐agent chemotherapy
por: Suzuki, Yuka, et al.
Publicado: (2020) -
PD‐L1 expression on tumor or stromal cells of nodal cytotoxic T‐cell lymphoma: A clinicopathological study of 50 cases
por: Yamashita, Daisuke, et al.
Publicado: (2020) -
An Update on the Pathology and Molecular Features of Hodgkin Lymphoma
por: Satou, Akira, et al.
Publicado: (2022)